Coronaric acid


Coronaric acid is a mono-unsaturated, epoxide derivative of the di-unsaturated fatty acid, linoleic acid,12. It is a mixture of the two optically active isomers of 12 9,10-epoxy-octadecenoic acid. This mixture is also termed 9,10-epoxy-12Z-octadecenoic acid or 9-EpOME and when formed by or studied in mammalians, leukotoxin.

Occurrence

Coronaric acid is found in the seed oils derived from plants in the sunflower family, such as Helianthus annuus and Xeranthemum annuum.
Coronaric acid is also formed by the cells and tissues of various mammalian species through the metabolism of linoleic acid by cytochrome P450 epoxygenase enzymes. These CYPs metabolize linoleic acid to 9S,10R-epoxy-12-octadecenoic acid and 9R,10S-epoxy-12-octadecenoic acid, i.e. the and epoxy optical isomers of coronaric acid. When studied in this context, the optical isomer mixture is often termed leukotoxin. These same CYP epoxygenases concurrently attack linoleic acid at the carbon 12,13 rather than 9,10 double bond of linoleic acid to form a mixture of and epoxy optical isomers viz., 12S,13R-epoxy-9-octadecenoic and 12R,13S-epoxy-9-octadecenoic acids. This and optical mixture is often termed vernolic acid when studied in plants and isoleukotoxin when studied in mammals.
Coronaric acid is found in urine samples from healthy human subjects and increases 3- to 4-fold when these subjects are treated with a salt-loading diet.
Coronaric and vernolic acids also form non-enzymatically when linoleic acid is exposed to oxygen and/or UV radiation as a result of the spontaneous process of autoxidation. This autoxidation complicates studies in that it is often difficult to determine if these epoxy fatty acids identified in linoleic acid-rich plant and mammalian tissues represent actual tissue contents or are artifacts formed during their isolation and detection.

Metabolism

In mammalian tissue, coronaric acid is metabolized to its two corresponding dihydroxy stereoisomers, 9S,10R-dihydroxy-12-octadecenoic and 9R,10S-dihydroxy-12-octadecenoic acids, by soluble [epoxide hydrolase] within minutes of its formation. The metabolism of coronaric acid to these two products, collectively termed leukotoxin diols, appears to be critical to coronaric acid's toxicity, i.e. the diols are the toxic metabolites of the non-toxic or far less toxic coronaric acid.

Activities

Toxicities

At very high concentrations, the linoleic acid-derived set of optical isomers, coronaric acid possesses toxicity similar to that of other structurally unrelated leukotoxins. It is toxic to leukocytes and other cell types, and when injected into rodents produces multiple organ failure and respiratory distress. These effects appear to be due to its conversion to its dihydroxy counterparts, 9S,10R- and 9R,10S-dihydroxy-12-octadecenoic acids by soluble epoxide hydrolase. Some studies suggest, but have not yet proven, that isoleukotoxin, acting primarily if not exclusively through its dihydroxy counterparts, is responsible for or contributes to multiple organ failure, the acute respiratory distress syndrome, and certain other cataclysmic diseases in humans. Vernolic acid shares a similar metabolic fate in being converted by soluble epoxide hydrolase to its dihydroxide counterparts, resulting in the toxic actions of those counterparts.

Other activities

At lower concentrations, isoleukotoxin and its dihydroxy counterparts can protect from the toxic actions cited above that occur at higher concentrations of isoleukotoxin and leukotoxin; they may also share with the epoxides of arachidonic acid, i.e. the epoxyeicosatreienoates, anti-hypertension activities.